Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Lifestyle shapes the dialog between environment, microglia, and adult neurogenesis.
Autoimmune disease: SIRT1 inhibition suppresses multiple sclerosis.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis.
Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies - Perspectives for immunoadsorption.
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
The Significance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
Reply to the Comment by Yolcu et al. on Our Paper Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
Cognitive dysfunction in pediatric multiple sclerosis.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.
SPG5 and multiple sclerosis: clinical and genetic overlap?
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Pages
« first
‹ previous
…
656
657
658
659
660
661
662
663
664
…
next ›
last »